New Zealand - engelsk - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - clobetasol propionate 0.5 mg/g - topical ointment - 0.5 mg/g - active: clobetasol propionate 0.5 mg/g excipient: propylene glycol sorbitan sesquioleate white soft paraffin - treatment of resistant dermatoses such as psoriasis (excluding widespread plaque psoriasis), recalcitrant eczemas, lichen planus and discoid lupus eyrthematosus and other skin conditions which do not respond satisfactorily to less active steroids.

USA - engelsk - NLM (National Library of Medicine)

dpt laboratories, ltd. - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) - clobetasol propionate 0.5 mg in 1 g

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - clobetasol propionate - cutaneous cream - 500microgram/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - clobetasol propionate - cutaneous cream - 500microgram/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - clobetasol propionate - cutaneous cream - 500microgram/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - clobetasol propionate - cutaneous ointment - 500microgram/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - clobetasol propionate - cutaneous cream - 500microgram/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - clobetasol propionate - cutaneous ointment - 500microgram/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - clobetasol propionate - cutaneous ointment - 500microgram/1gram

USA - engelsk - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) - clobetasol propionate topical solution is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp. treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 ml/week because of the potential for the drug to suppress the hpa axis. this product is not recommended for use in pediatric patients under 12 years of age. clobetasol propionate topical solution is contraindicated in patients with primary infections of the scalp, or in patients who are hypersensitive to clobetasol propionate, other corticosteroids, or any ingredient in this preparation.